21 CFR Part 520 - Oral Dosage Form New Animal Drugs Orbifloxacin Suspension

• Date: May 12, 2010
• Source: http://edocket.access.gpo.gov/

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Intervet, Inc. The NADA provides for the veterinary prescription use of an oral suspension containing orbifloxacin for the treatment of various bacterial infections in dogs and cats.

DATES: This rule is effective May 12, 2010.

 

Click here to download the file